Q702 treatment inhibited the phosphorylation of Axl and CSF1R in H1299 and M-NFS-60 tumor samples, respectively, indicating that Q702 inhibits Axl and CSF1R activation in a physiological setting. The gene discussed is CSF1R; the disease is neoplasm.